🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
DCT
$DCTH
🔒 US EquitiesDelcath Systems Inc
AVG HISTORICAL GAP
+3.53%
MAX GAP RECORD
+18.80%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $DCTH
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$DCTH
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Nov 03, 2026 Earnings Release 2026-11-03 (BEFORE OPEN (07:00)) | 🔮 UPCOMING 🔒 |
| Aug 06, 2026 Earnings Release 2026-08-06 (BEFORE OPEN) |
+11.08%
|
| May 07, 2026 Earnings Release 2026-05-07 (BEFORE OPEN) |
+2.22%
|
| Feb 26, 2026 Earnings Release 2026-02-26 (BEFORE OPEN) |
-7.64%
|
| Nov 04, 2025 Earnings Release 2025-11-04 (BEFORE OPEN) |
-4.62%
|
| Aug 06, 2025 Earnings Release 2025-08-06 (BEFORE OPEN) |
+18.16%
|
| May 07, 2025 Earnings Release 2025-05-07 (BEFORE OPEN) |
-1.96%
|
| Mar 06, 2025 Earnings Release 2025-03-06 (BEFORE OPEN) |
-3.50%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
6.3%
Bullish Gaps (8)
Bearish Gaps (6)
Neutral / Flat (1)
📖 Intelligence Summary
Delcath Systems, Inc. is an oncology company, which engages in the treatment of primary and metastatic liver cancers. Its products include CHEMOSAT and HEPZATO. The company was founded on August 5, 1988 and is headquartered in Queensbury, NY.
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗